EUCTR2006-006191-38-IT进行中(未招募)不适用
The effects of the association bindarit irbesartan versus irbesartan alone on albuminuria of patients with Diabetic Nephropathy. Placebo-controlled study. - ND
ANGELINI0 个研究点开始时间: 2007年3月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients may be enrolled under the following circumstances males and females patients with no limitation of race, aged 30 to 70 years; Type 2 diabetes defined as 30 years of age at diagnosis; insulin not required within 6 months of initial diagnosis; no history of diabetic ketoacidosis; currently treated with diet, oral hypoglycemics or insulin Brenner 2000 ; microalbuminuria defined as urinary albumin excretion, 20 to 200 g/min in at least 2 of 3 overnight urine samples or macroalbuminuria defined as urinary albumin excretion, 200 g/min in at least 2 of 3 overnight urine samples, confirmed in the baseline collection; should baseline albuminuria data not to be available, the patient may be conditionally treated; glycosylated haemoglobin Hb A1c 12 Brenner 2000 ; serum creatinine 8804; 3 mg/dL; normotensive patients or hypertensive patients on stable antihypertensive therapy over the last 3 months and without specific contraindications to angiotensin antagonist therapy; female patients of childbearing potential required to have a negative pregnancy test and use an approved birth control method; written informed consent to the trial signed and dated by the patient.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients cannot enter the trial under the following circumstances patients hypersensitive or allergic to ARBs, or with a positive history for drug allergy; Type 1 diabetes Brenner 2000 ; history of non diabetic renal disease, including renal artery stenosis Brenner 2000 ; history of heart failure before enrolment Brenner 2000 ; acute myocardial infarction, coronary artery bypass grafting within the past one month Brenner 2000 ; cerebral vascular accident or coronary angioplasty within the past six months month Brenner 2000 ; Transient Ischemic Attacks TIA in the past 12 months Brenner 2000 ; primary aldosteronism or pheocromocytoma Brenner 2000 ; severe uncontrolled hypertension sitting diastolic blood pressure 115 and/or sitting systolic blood pressure 220 mm Hg in the previous 6 months; chronic use of corticosteroids, non-steroidal anti-inflammatory drugs, immunosuppressive drugs, MAO inhibitors; patients under the influence of alcohol or narcotics; patients treated with experimental drugs in the previous 4 weeks.
研究者
相似试验
进行中(未招募)
1 期
The effects of the association bindarit + irbesartan versus irbesartan alone on albuminuria of patients with Diabetic Nephropathy. Double-blind placebo-controlled study followed by an open extension phase.Diabetic Nephropathy (Type 2 diabetes)MedDRA version: 9.1Level: LLTClassification code 10061835Term: Diabetic nephropathyEUCTR2006-006191-38-SIAngelini Farmaceutici, ACRAF S.p.A.50
已完成
2 期
The effect of your Irbesartan drug in treatment of hepatitis B and DHepatitis B and D.Chronic viral hepatitis B with delta-agentIRCT2017071128308N3Vice chancellor for research Tehran University of Medical Sciences45
已完成
4 期
Effects of the combination therapy of irbesartan and indapamide in chronik kidney disease with hypertensiochronick kidney disease with hypertensionJPRN-UMIN000010787Division of Nephrology, Department of Internal medicine, Jichi Medical University30
招募中
不适用
Effect of on combination therapy with irbesartan and amlodipine besilate on clinical blood pressure, home blood pressure and blood pressure variability in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD G1-G4)JPRN-UMIN000013213Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
已完成
2 期
The Effects of Bindarit in Diabetic NephropathyDiabetic NephropathyNCT01109212Aziende Chimiche Riunite Angelini Francesco S.p.A100
